Kewaunee Scientific (NASDAQ:KEQU) Posts Earnings Results

Kewaunee Scientific (NASDAQ:KEQU) released its quarterly earnings results on Wednesday. The technology company reported $1.09 earnings per share (EPS) for the quarter, Zacks reports. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Kewaunee Scientific Price Performance

Shares of Kewaunee Scientific stock opened at $49.20 on Thursday. The firm has a fifty day simple moving average of $59.17 and a 200-day simple moving average of $47.96. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45. Kewaunee Scientific has a 1-year low of $29.95 and a 1-year high of $71.33. The stock has a market capitalization of $141.30 million, a price-to-earnings ratio of 7.80 and a beta of 0.71.

Insider Transactions at Kewaunee Scientific

In related news, VP Douglas J. Batdorff sold 3,470 shares of the company’s stock in a transaction on Monday, December 30th. The shares were sold at an average price of $65.50, for a total transaction of $227,285.00. Following the completion of the transaction, the vice president now directly owns 5,000 shares in the company, valued at $327,500. This represents a 40.97 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Donald T. Gardner III sold 1,257 shares of the company’s stock in a transaction on Friday, January 10th. The shares were sold at an average price of $59.26, for a total transaction of $74,489.82. Following the transaction, the chief financial officer now owns 21,358 shares of the company’s stock, valued at approximately $1,265,675.08. The trade was a 5.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 11,994 shares of company stock worth $729,430. 14.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Kewaunee Scientific

An institutional investor recently raised its position in Kewaunee Scientific stock. Bank of America Corp DE increased its position in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) by 2,605.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 460 shares of the technology company’s stock after purchasing an additional 443 shares during the quarter. Bank of America Corp DE’s holdings in Kewaunee Scientific were worth $28,000 at the end of the most recent quarter. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.